Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma
NCT02345408
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
CCX872-B
Sponsor
Amgen